CD274 and neoplasm: Mice treated with monotherapies (anti-PD-L1 or TTFields) demonstrated a mild decrease in tumor volume as compared to the control group, while concomitant treatment of TTFields and anti-PD-L1 led to a significant decrease in tumor volume as compared to the other 3 groups (Figure 3B).